Alibaba's AI tool boosts small businesses in Europe and the Americas by enhancing online visibility and market reach, transforming European commerce.
Neurogene Inc. secures $200M to advance NGN-401 for Rett syndrome and fuel corporate growth, extending its runway into 2027.
Pfizer released its third-quarter 2024 financial results on October 29, 2024, highlighting strategic growth and a $1.5 billion revenue guidance increase.
Explore how a renewed Trump administration could reshape the biopharma sector through policy shifts, M&A, and strategic growth opportunities.
Master in-depth equity analysis for biotech startups, focusing on financial health, product pipeline, and management to identify promising ventures.
Nintendo shifts focus to digital content amid declining Switch sales, considering a new console to stay competitive in the evolving gaming market.
BioNTech eases 2024 revenue outlook to €2.5-€3.1B due to shifting COVID-19 vaccine demand and pricing adjustments.
Over the past decade, the European market has exhibited remarkable growth and resilience. The total market capitalization of the top 50 companies in key EU countries more than doubled...
Uber's Q3 2024 results beat revenue expectations, yet stock fell. Explore market reactions, regulatory risks, and future growth potential.
GSK's acquisition of Chimagen Biosciences enhances its autoimmune portfolio with CMG1A46, a promising therapy for lupus, expanding treatment options and innovation.